BridgeBio Pharma and Kyowa Kirin Announce Partnership with
- BridgeBio grants Kyowa Kirin exclusive license to develop and commercialize infigratinib for skeletal dysplasias in Japan - BridgeBio to receive...
Source: globenewswire.com
Page 4 - Neil Kumar News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Neil Kumar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Neil Kumar Today - Breaking & Trending Today
How to invest in real estate, but mind the risks
REITs and private real estate investment funds offer exposure to market, but don't scrimp on due diligence. Read more from
Source: leaderpost.com
Sphere Studio's 18K Big Sky Sensor Tech Has Been Revealed
A scientific journal article sheds new light on the insane 18K x 18K image sensor being used to make content for Sphere in Las Vegas.
Source: petapixel.com
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives $37.30 Average Price Target from Analysts
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the ten analysts that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold rating and nine have issued a buy rating on the company. The average twelve-month price target […]
Source: dailypolitical.com
Moody Aldrich Partners LLC Sells 64,980 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO)
Moody Aldrich Partners LLC lessened its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 44.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 79,873 shares of the company’s stock after selling 64,980 shares during the period. Moody […]
Source: wkrb13.com